<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04846192</url>
  </required_header>
  <id_info>
    <org_study_id>2021PI058</org_study_id>
    <nct_id>NCT04846192</nct_id>
  </id_info>
  <brief_title>Prognosis of Nutritional Status for Surgical Peri Hilar Cholangiocarcinoma</brief_title>
  <official_title>Prognosis of Nutritional Status for Surgical Peri Hilar Cholangiocarcinoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Curative treatment of peri hilar cholangiocarcinomas is R0 surgery and require major&#xD;
      hepatectomy with biliary tract resection. These complexe procedures can lead to high&#xD;
      morbidity and mortality. A severe alteration of nutritional status before the surgery might&#xD;
      be a poor prognosis for survival.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Peri hilar cholangiocarcinomas are rare tumors, which when diagnosed at the resectable stage,&#xD;
      require major hepatic resection associated with biliary reconstruction. These are complex&#xD;
      procedures with a high morbidity and mortality, mainly due to postoperative hepatic failure&#xD;
      and sepsis.&#xD;
&#xD;
      These patients undergo optimization of liver function with portal embolization according to&#xD;
      the volume of the future remaining liver and preoperative biliary drainage. On top of&#xD;
      technical challenges of the surgery, the patients usually present a significant alteration of&#xD;
      the general condition at the time of diagnosis, with denutrition that can be severe. The&#xD;
      importance of evaluating the preoperative nutritional status in the context of oncological&#xD;
      surgery is increasingly recognized in the literature. Different nutritional scores exist such&#xD;
      as the CONUT score, PNI, or the evaluation of sarcopenia on imaging examinations and have&#xD;
      shown an impact on morbi-mortality in liver surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">April 2021</start_date>
  <completion_date type="Anticipated">May 2021</completion_date>
  <primary_completion_date type="Anticipated">May 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Overall Survival</measure>
    <time_frame>01/01/2003 to 04/01/2021</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Disease Free Survival</measure>
    <time_frame>01/01/2003 to 04/01/2021</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Morbidity</measure>
    <time_frame>01/01/2003 to 04/01/2021</time_frame>
    <description>Post operative complications : Dindo-Clavien &gt; or = 3</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Perihilar Cholangiocarcinoma</condition>
  <arm_group>
    <arm_group_label>Patients</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Nutritional evaluation</intervention_name>
    <description>Collecting existing data on pre operative nutritional status and outcomes after surgery</description>
    <arm_group_label>Patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Surgical peri hilar cholangiocarcinoma at Nancy University Hospital&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Surgical peri hilar cholangiocarcinoma from 01/01/2003 to 04/01/2021 at Nancy&#xD;
             University Hospital&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Non curative surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahmet Ayav, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Central Hospital, Nancy, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Julie Leclerc, MD</last_name>
    <phone>0383154207</phone>
    <email>j.leclerc@chru-nancy.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHRU de Nancy</name>
      <address>
        <city>Vandœuvre-lès-Nancy</city>
        <zip>54500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Leclerc</last_name>
      <phone>0383154207</phone>
      <email>j.leclerc@chru-nancy.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Otsuji H, Yokoyama Y, Ebata T, Igami T, Sugawara G, Mizuno T, Nagino M. Preoperative sarcopenia negatively impacts postoperative outcomes following major hepatectomy with extrahepatic bile duct resection. World J Surg. 2015 Jun;39(6):1494-500. doi: 10.1007/s00268-015-2988-6.</citation>
    <PMID>25651963</PMID>
  </reference>
  <reference>
    <citation>Golse N, Nunez J, Mazzotta A, Cano L, Bergeat D, Sulpice L, Jeddou H, Abdelrafee A, Sa Cunha A, Cherqui D, Adam R, Boudjema K, Vibert E. Personalized Preoperative Nomograms Predicting Postoperative Risks after Resection of Perihilar Cholangiocarcinoma. World J Surg. 2020 Oct;44(10):3449-3460. doi: 10.1007/s00268-020-05618-8.</citation>
    <PMID>32474628</PMID>
  </reference>
  <reference>
    <citation>Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet. 2019 Jun 29;393(10191):2636-2646. doi: 10.1016/S0140-6736(19)31138-9. Epub 2019 Jun 3. Review. Erratum in: Lancet. 2019 Jun 29;393(10191):2590.</citation>
    <PMID>31171417</PMID>
  </reference>
  <results_reference>
    <citation>Yugawa K, Itoh S, Kurihara T, Yoshiya S, Mano Y, Takeishi K, Harada N, Ikegami T, Soejima Y, Mori M, Yoshizumi T. Skeletal muscle mass predicts the prognosis of patients with intrahepatic cholangiocarcinoma. Am J Surg. 2019 Nov;218(5):952-958. doi: 10.1016/j.amjsurg.2019.03.010. Epub 2019 Mar 14.</citation>
    <PMID>30902342</PMID>
  </results_reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>April 12, 2021</study_first_submitted>
  <study_first_submitted_qc>April 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 15, 2021</study_first_posted>
  <last_update_submitted>April 12, 2021</last_update_submitted>
  <last_update_submitted_qc>April 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>sarcopenia</keyword>
  <keyword>nutritional status</keyword>
  <keyword>surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholangiocarcinoma</mesh_term>
    <mesh_term>Klatskin Tumor</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

